Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FDU29
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,982
Award facts
- Contract value 100% obligated
- $22,982.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,982.14 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen 2 mL injections. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued on October 27, 2025, with an ultimate completion date of October 28, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and the U.S. Coast Guard. Cosentyx is a specialty immunosuppressant medication used to treat autoimmune conditions, reflecting the breadth of therapeutic domains covered under the company's federal pharmaceutical supply contracts.
Quick answers
Who was awarded contract SPE2DB26FDU29?
SPE2DB26FDU29 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FDU29 worth?
The government has obligated $22,982 on SPE2DB26FDU29.
Is contract SPE2DB26FDU29 an order under another contract?
Yes. SPE2DB26FDU29 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDU29 competed?
The extent of competition for SPE2DB26FDU29 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award